|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent AHT insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why AHT insider buys are important for investors to follow.
Date | Insider | Price | Amount |
8-16-2021 Insider Buy |
J. Robison Hays III President and CEO |
$13.54
CAGR »
|
$101,550.00 7,500 shares |
4-15-2021 Insider Buy |
Benjamin J. Ansell, M.D. Director |
$2.06
CAGR »
|
$206,500.00 100,000 shares |
8-28-2020 Insider Buy |
Benjamin J. Ansell, M.D. Director |
$2.92
CAGR »
|
$146,000.00 50,000 shares |
8-7-2020 Insider Buy |
Benjamin J. Ansell, M.D. Director |
$3.85
CAGR »
|
$38,500.00 10,000 shares |
3-19-2020 Insider Buy |
Benjamin J. Ansell, M.D. Director |
$0.50
CAGR »
|
$25,000.00 50,000 shares |
8-27-2019 Insider Buy |
Mark Nunneley Chief Accounting Officer |
$2.38
CAGR »
|
$95,200.00 40,000 shares |
6-25-2019 Insider Buy |
Benjamin J. Ansell, M.D. Director |
$2.90
CAGR »
|
$72,500.00 25,000 shares |
6-18-2019 Insider Buy |
Benjamin J. Ansell, M.D. Director |
$3.36
CAGR »
|
$67,200.00 20,000 shares |
5-27-2016 Insider Buy |
Benjamin J. Ansell, M.D. Director |
$4.95
CAGR »
|
$14,850.00 3,000 shares |
5-12-2016 Insider Buy |
Benjamin J. Ansell, M.D. Director |
$5.66
CAGR »
|
$32,828.00 5,800 shares |
12-11-2015 Insider Buy |
Thomas E. Callahan Director |
$6.18
CAGR »
|
$49,440.00 8,000 shares |
11-10-2015 Insider Buy |
Thomas E. Callahan Director |
$6.52
CAGR »
|
$50,856.00 7,800 shares |
11-9-2015 Insider Buy |
Benjamin J. Ansell, M.D. Director |
$6.53
CAGR »
|
$48,969.90 7,500 shares |
11-12-2013 Insider Buy |
Benjamin J. Ansell, M.D. Director |
$8.00
CAGR »
|
$50,080.00 6,260 shares |
11-5-2013 Insider Buy |
Thomas E. Callahan Director |
$12.75
CAGR »
|
$63,750.00 5,000 shares |
11-6-2013 Insider Buy |
Benjamin J. Ansell, M.D. Director |
$8.50
CAGR »
|
$42,500.00 5,000 shares |
5-1-2012 Insider Buy |
Benjamin J. Ansell, M.D. Director |
$8.69
CAGR »
|
$34,760.00 4,000 shares |
3-1-2012 Insider Buy |
Montgomery J. Bennett Chief Executive Officer |
$8.70
CAGR »
|
$250,135.25 28,736 shares |
2-28-2012 Insider Buy |
Montgomery J. Bennett Chief Executive Officer |
$8.65
CAGR »
|
$248,485.83 28,736 shares |
9-21-2011 Insider Buy |
Benjamin J. Ansell, M.D. Director |
$6.68
CAGR »
|
$13,360.00 2,000 shares |
8-23-2011 Insider Buy |
Montgomery J. Bennett Chief Executive Officer |
$7.22
CAGR »
|
$212,841.43 29,481 shares |
8-19-2011 Insider Buy |
Montgomery J. Bennett Chief Executive Officer |
$7.65
CAGR »
|
$225,656.92 29,482 shares |
8-11-2011 Insider Buy |
Montgomery J. Bennett Chief Executive Officer |
$8.50
CAGR »
|
$85,693.29 10,080 shares |
8-10-2011 Insider Buy |
Thomas E. Callahan Director |
$7.58
CAGR »
|
$51,789.50 6,832 shares |
8-10-2011 Insider Buy |
Montgomery J. Bennett Chief Executive Officer |
$7.65
CAGR »
|
$231,493.96 30,243 shares |
4-25-2011 Insider Buy |
Capital Preferred Growth Inc Security >10% Owner |
$12.20
CAGR »
|
$480,680.00 39,400 shares |
4-21-2011 Insider Buy |
Capital Preferred Growth Inc Security >10% Owner |
$11.68
CAGR »
|
$4,534,147.00 388,200 shares |
4-11-2011 Insider Buy |
Capital Preferred Growth Inc Security >10% Owner |
$11.08
CAGR »
|
$598,320.00 54,000 shares |
3-22-2011 Insider Buy |
Capital Preferred Growth Inc Security >10% Owner |
$9.58
CAGR »
|
$1,553,999.00 162,200 shares |
2-24-2011 Insider Buy |
Thomas E. Callahan Director |
$9.72
CAGR »
|
$45,665.00 4,700 shares |
3-21-2011 Insider Buy |
Benjamin J. Ansell, M.D. Director |
$9.95
CAGR »
|
$62,189.92 6,250 shares |
Also See: Institutional Holders of AHT
Also See: SEC filings
Below we present the annualized performance delivered by AHT stock since 8-16-2021 (the date of the most recent
insider purchase). The performance of the investment from the time AHT insider buying occurred is the ultimate
test of whether insiders were right about AHT being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
08/17/2021 |
|
End date: |
04/17/2024 |
|
Start price/share: |
$13.37 |
|
End price/share: |
$1.31 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-90.20% |
|
Average Annual Total Return: |
-58.13% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$979.60 |
|
Years: |
2.67 |
|
AHT Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent AHT insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding AHT
|
|